Bolt Biotherapeutics, Inc.
BOLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $409 | $847 | $971 | $3,665 |
| - Cash | $7 | $11 | $9 | $27 |
| + Debt | $25 | $20 | $23 | $24 |
| Enterprise Value | $427 | $856 | $985 | $3,662 |
| Revenue | $8 | $8 | $6 | $1 |
| % Growth | -2.4% | 37.5% | 354.7% | – |
| Gross Profit | $8 | -$54 | -$67 | -$74 |
| % Margin | 100% | -681.4% | -1,176.4% | -5,904.4% |
| EBITDA | -$66 | -$74 | -$89 | -$92 |
| % Margin | -864.2% | -943.9% | -1,547.5% | -7,269.4% |
| Net Income | -$63 | -$69 | -$88 | -$99 |
| % Margin | -820.8% | -878.6% | -1,537.8% | -7,824.7% |
| EPS Diluted | -1.65 | -1.83 | -2.3 | -2.79 |
| % Growth | 9.8% | 20.4% | 17.6% | – |
| Operating Cash Flow | -$61 | -$70 | -$77 | -$57 |
| Capital Expenditures | -$0 | -$0 | -$2 | -$2 |
| Free Cash Flow | -$61 | -$70 | -$78 | -$59 |